Literature DB >> 26616284

An architecture for a continuous, user-driven, and data-driven application of clinical guidelines and its evaluation.

Erez Shalom1, Yuval Shahar2, Eitan Lunenfeld3.   

Abstract

OBJECTIVES: Design, implement, and evaluate a new architecture for realistic continuous guideline (GL)-based decision support, based on a series of requirements that we have identified, such as support for continuous care, for multiple task types, and for data-driven and user-driven modes.
METHODS: We designed and implemented a new continuous GL-based support architecture, PICARD, which accesses a temporal reasoning engine, and provides several different types of application interfaces. We present the new architecture in detail in the current paper. To evaluate the architecture, we first performed a technical evaluation of the PICARD architecture, using 19 simulated scenarios in the preeclampsia/toxemia domain. We then performed a functional evaluation with the help of two domain experts, by generating patient records that simulate 60 decision points from six clinical guideline-based scenarios, lasting from two days to four weeks. Finally, 36 clinicians made manual decisions in half of the scenarios, and had access to the automated GL-based support in the other half. The measures used in all three experiments were correctness and completeness of the decisions relative to the GL.
RESULTS: Mean correctness and completeness in the technical evaluation were 1±0.0 and 0.96±0.03 respectively. The functional evaluation produced only several minor comments from the two experts, mostly regarding the output's style; otherwise the system's recommendations were validated. In the clinically oriented evaluation, the 36 clinicians applied manually approximately 41% of the GL's recommended actions. Completeness increased to approximately 93% when using PICARD. Manual correctness was approximately 94.5%, and remained similar when using PICARD; but while 68% of the manual decisions included correct but redundant actions, only 3% of the actions included in decisions made when using PICARD were redundant.
CONCLUSIONS: The PICARD architecture is technically feasible and is functionally valid, and addresses the realistic continuous GL-based application requirements that we have defined; in particular, the requirement for care over significant time frames. The use of the PICARD architecture in the domain we examined resulted in enhanced completeness and in reduction of redundancies, and is potentially beneficial for general GL-based management of chronic patients.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical decision support systems; Clinical practice guidelines; Computer-assisted decision-making; Evaluation; Guideline execution engine; Guideline simulation; Health care quality assurance; Knowledge representation; Telemedicine

Mesh:

Year:  2015        PMID: 26616284     DOI: 10.1016/j.jbi.2015.11.006

Source DB:  PubMed          Journal:  J Biomed Inform        ISSN: 1532-0464            Impact factor:   6.317


  4 in total

1.  A Review of Challenges and Opportunities in Machine Learning for Health.

Authors:  Marzyeh Ghassemi; Tristan Naumann; Peter Schulam; Andrew L Beam; Irene Y Chen; Rajesh Ranganath
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2020-05-30

2.  A Methodological Framework for the Integrated Design of Decision-Intensive Care Pathways-an Application to the Management of COPD Patients.

Authors:  Carlo Combi; Barbara Oliboni; Alessandro Zardini; Francesca Zerbato
Journal:  J Healthc Inform Res       Date:  2017-10-17

Review 3.  Mobile Health Solutions for Hypertensive Disorders in Pregnancy: Scoping Literature Review.

Authors:  Octavio Rivera-Romero; Alberto Olmo; Rocío Muñoz; Pablo Stiefel; María Luisa Miranda; Luis M Beltrán
Journal:  JMIR Mhealth Uhealth       Date:  2018-05-30       Impact factor: 4.773

Review 4.  The use of computer-interpretable clinical guidelines to manage care complexities of patients with multimorbid conditions: A review.

Authors:  Eda Bilici; George Despotou; Theodoros N Arvanitis
Journal:  Digit Health       Date:  2018-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.